Results of the LEVEL Study

Show Description +

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Results of the LEVEL Study

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Please log in to leave a comment.

More in Retina

Can LLMs Conduct Human-level Research?

Maria Berrocal, MD; Ariel Ong, MD; and David Merle, MD

Susvimo: Final Thoughts

Kourous Rezaei, MD; Frank Brodie, MD, MBA; Margaret Chang, MD, MS; and Deepika Malik, MD

Susvimo: Implant Refill

Kourous Rezaei, MD; Frank Brodie, MD, MBA; Margaret Chang, MD, MS; and Deepika Malik, MD